DECHRA LIMITED

Active
Company number 04513124Private limited companyIncorporated 2002

Key figures

£780,100,000
Net assets 2024/25

† DECHRA LIMITED filed these accounts on paper, so Companies House publishes them only as a scanned image. The figures for the years marked † were read automatically from the scan and kept only where the statements add up (for example net assets equal total equity), but a reading error is still possible — check the original accounts at Companies House.

Ratios

2024/25

Sector comparison

SIC 21100

Where the company stands among the 1,055 active companies whose first SIC code is 21100 (Manufacture of basic pharmaceutical products).

Turnover£136,070,000
Higher than 81% · median £23,360,137 among 97 that publish turnover
Net assets£780,100,000
Higher than 99% · median £41,497
Total assets£994,770,000
Higher than 99% · median £308,978
Cash£59,000
Lower than 59% · median £135,555
Employees397
Higher than 97% · median 1
Company age24.2 years
Older than 80% · median 9.0 years
Largest in this sector by net assets
  1. GE HEALTHCARE LIMITED£5.6bn
  2. THERMO FISHER SCIENTIFIC LIFE HOLDINGS LIMITED£1.4bn
  3. LRC PRODUCTS LIMITED£1bn
  4. SMITHKLINE BEECHAM LIMITED£940m
  5. DECHRA LIMITED£780.1m
  6. IPSEN BIOPHARM LIMITED£588.2m
  7. ORTHO-CLINICAL DIAGNOSTICS£295.7m
  8. BESPAK EUROPE LIMITED£256m
  9. SEQIRUS VACCINES LIMITED£254.2m
  10. IOVANCE BIOTHERAPEUTICS UK LTD£199.7m

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 1,055. The line on each bar marks the median.

Summary: DECHRA LIMITED

What kind of company is it?

DECHRA LIMITED is a private limited company registered with Companies House under company number 04513124. It was incorporated on 16 Aug 2002. Its status is active. The registered office is in Skipton (BD23). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), veterinary activities (75000).

How is the company doing financially?

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files audit-exempt subsidiary. Turnover was £136,070,000. Loss for the year was £28,760,000. Net assets were £780,100,000. Cash at bank and in hand was £59,000. Total assets were £994,770,000 and total liabilities £214,670,000. The company had an average of 397 employees.

How does it compare with similar companies?

Compared with 1,055 active companies whose first SIC code is 21100: By turnover it ranks higher than 81% of the 97 that publish turnover (median £23,360,137). By net assets it ranks higher than 99% of them (median £41,497). By total assets it ranks higher than 99% of them (median £308,978). By cash it ranks lower than 59% of them (median £135,555). By number of employees it ranks higher than 97% of them (median 1). It is older than 80% of them (median age 9.0 years).

What do public registers and reports show?

It appears on the Home Office register of licensed sponsors (Skilled Worker). In its latest payment practices report it took an average of 39 days to pay suppliers, and 24% of invoices were not paid within agreed terms. Its gender pay gap report for 2025/26 shows median hourly pay for women 3.7% lower than for men. It has modern slavery statements on the government registry for 6 years.

Who runs and controls the company?

One person with significant control is registered. 1 of 6 registered charges are outstanding.

When are its next filings due?

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 29 May 2027.

Filed accounts2024/25
2024/25 †
Turnover136,070,000
Profit for the year-28,760,000
Cash at bank and in hand59,000
Total assets994,770,000
Total liabilities214,670,000
Net assets / total equity780,100,000
Average number of employees397

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Statutory reporting

Payment practices1 Jan 2026 – 30 Jun 2026
Average time taken to pay invoices
39 days
Invoices not paid within agreed terms
24%
Standard payment terms
1–90 days
Member of a payment code
No
  • Within 30 days 38%
  • 31 to 60 days 50%
  • After 60 days 12%
Earlier periods (7)
Period ending
Days to pay
Within 30 days
Late
31 Dec 2025
40
29%
35%
30 Jun 2025
40
32%
38%
31 Dec 2024
40
32%
35%
30 Jun 2024
44
27%
28%
31 Dec 2023
46
25%
22%
30 Jun 2023
44
27%
16%
31 Dec 2022
45
23%
22%

View the latest report on GOV.UK

Gender pay gap2025/26
Median hourly pay
women 3.7% lower
Mean hourly pay
women 5.8% lower
Median bonus pay
women 5.5% lower
Employer size
250 to 499 employees
Lower pay quarter48% womenLower middle47% womenUpper middle50% womenUpper pay quarter42% women
Earlier years (8)
Year
Median hourly pay
Mean hourly pay
2024/25
women 6.3% lower
women 7.4% lower
2023/24
women 9.6% lower
women 12.6% lower
2022/23
women 1.3% lower
women 10.3% lower
2021/22
women 2.8% lower
women 9.4% lower
2020/21
women 5.5% lower
women 7.8% lower
2019/20
women 7.4% lower
women 10.1% lower
2018/19
women 9.2% lower
women 11.5% lower
2017/18
women 17.7% lower
women 16.2% lower

A positive gap means women's average hourly pay is lower than men's across the whole employer; it is not a comparison of pay for the same work. View on the Gender pay gap service

Modern slavery statements6
2025
Statement · summary on GOV.UK · group statement (DECHRA PHARMACEUTICALS LIMITED)
2024
Statement · summary on GOV.UK · group statement (DECHRA PHARMACEUTICALS LIMITED)
2023
Statement · summary on GOV.UK · group statement (DECHRA PHARMACEUTICALS LIMITED)
Earlier years (3)
2022
Statement · summary on GOV.UK · group statement (DECHRA PHARMACEUTICALS LIMITED)
2021
Statement · summary on GOV.UK · group statement (DECHRA PHARMACEUTICALS LIMITED)
2020
Statement registered · summary on GOV.UK · group statement (DECHRA PHARMACEUTICALS LIMITED)

Figures the company reported itself to the government's Check payment practices service, Gender pay gap service and Modern slavery statement registry (Open Government Licence v3.0). Only large companies and employers with 250 or more staff have to report, so most companies have nothing here.

Registers and licences

Sponsor licence‡
Licence type and rating
Worker (A rating)
Route
Skilled Worker

On the Home Office register of licensed sponsors, which lists organisations licensed to sponsor workers from overseas.

Sources: Charity Commission for England and Wales, Care Quality Commission, Home Office and HM Revenue & Customs, under the Open Government Licence v3.0. Entries marked ‡ come from lists that do not state a company number and were linked by an exact match on the registered name.

History

3 events
  1. Financial year 2024/25 endedAccounts: turnover £136.1m, net assets £780.1m, 397 employees
  2. Dechra Investments Limited registered as a person with significant control
  3. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.